Metoclopramide NDC 68071-5314

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-5314Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-5314Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-5314-6	68071531406	6 TABLET in 1 BOTTLE (68071-5314-6)Marketed from Aug 10, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Metoclopramide
Generic name (nonproprietary): metoclopramide
Active ingredients: Metoclopramide hydrochloride — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: NuCare Pharmaceuticals,Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078807
Marketing start: Jan 9, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Dopamine D2 Antagonists (Mechanism)
Identifiers: Product ID 68071-5314_58b3664f-133a-c44c-e063-6294a90ab184SPL ID 58b3664f-133a-c44c-e063-6294a90ab184SPL set ID 58b3666f-ac0f-811e-e063-6394a90a8e04RxCUI 311668UNII W1792A2RVDUPC 0368071531466
Pharmacologic class: Dopamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071531406 followed by a unit qualifier and the quantity

Package 68071-5314-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 10, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Metoclopramide tablets are indicated for the: Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy. ( 1 ) Relief of symptoms in adults with acute and recurrent diabetic gastroparesis. ( 1 ) Limitations of Use: Metoclopramide tablets have not been shown to be safe and effective for the treatment of gastroesophageal reflux for longer than 12 weeks. ( 1 , 5.1 ) Metoclopramide tablets are not recommended for use in pediatric patients due to the risk of tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates. ( 1 , 8.4 ) Metoclopramide tablets are indicated for th…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078807

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078807
Product	Strength	Form · route	Labeler	Product NDC
Metoclopramide	Metoclopramide hydrochloride 5 mg/1	TabletOral	Ipca Laboratories Limited	83980-010
Metoclopramide	Metoclopramide hydrochloride 10 mg/1	TabletOral	Ipca Laboratories Limited	83980-011
Metoclopramide	Metoclopramide hydrochloride 5 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-5303
Metoclopramide	Metoclopramide hydrochloride 10 mg/1	TabletOral	Redpharm Drug	67296-2309